Georgetown Lombardi, Washington's only National Cancer Institute-designated Comprehensive Cancer Center, works with other institutions - MedStar Health and the John Theurer Cancer Center - to broaden its research capacity.
Annual Fund Drive Ends March 31!
Your support is critical to new clinical trials and discoveries that will help us find a cure. Please give today to help defeat cancer and save lives!
We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.
Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!
Educating and training tomorrow's leaders in cancer treatment and research is our mission.
Discover what distinguishes Georgetown Lombardi Comprehensive Cancer Center,
Washington, D.C.’s only National Cancer Institute-designated Comprehensive Cancer Center.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi's research.
Meet 
Georgetown University Medical Center is an internationally recognized academic health and science center with a four-part mission of research, teaching, service and patient care (provided through a partnership with MedStar Health).
Lombardi News Stories
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
-
Facing a Difficult Diagnosis, Why One Patient Chooses to Confront Cancer at Georgetown Lombardi
-
Carnegie Renews Classification of Georgetown as ‘Very High Research University’
-
Genetic Testing of Women Diagnosed with Breast Cancer Could Be 'Impactful'